Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease.

Sumner MD, Elliott-Eller M, Weidner G, Daubenmier JJ, Chew MH, Marlin R, Raisin CJ, Ornish D.

Am J Cardiol. 2005 Sep 15;96(6):810-4.

PMID:
16169367
2.

Site of myocardial infarction and severity of perfusion abnormalities impact on post-stress left ventricular function in patients with single-vessel disease: gated single-photon emission computed tomography methoxyisobutylisonitrile study.

Sobic-Saranovic DP, Pavlovic SV, Beleslin BD, Petrasinovic ZR, Kozarevic NDj, Todorovic-Tirnanic MV, Ille TM, Jaksic ED, Artiko VM, Obradovic VB.

Nucl Med Commun. 2009 Feb;30(2):148-54. doi: 10.1097/MNM.0b013e3283176a67.

PMID:
19077915
3.

Acceleration of hepatobiliary excretion by lemon juice on 99mTc-tetrofosmin cardiac SPECT.

Cherng SC, Chen YH, Lee MS, Yang SP, Huang WS, Cheng CY.

Nucl Med Commun. 2006 Nov;27(11):859-64.

PMID:
17021425
4.

Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.

Davidson MH, Maki KC, Dicklin MR, Feinstein SB, Witchger M, Bell M, McGuire DK, Provost JC, Liker H, Aviram M.

Am J Cardiol. 2009 Oct 1;104(7):936-42. doi: 10.1016/j.amjcard.2009.05.037.

PMID:
19766760
5.

Evaluation of myocardial perfusion and function by gated SPECT in patients with Beh├žet's disease.

Kaya E, Saglam H, Ciftci I, Kulac M, Karaca S, Melek M.

Ann Nucl Med. 2008 May;22(4):287-95. doi: 10.1007/s12149-007-0115-y. Epub 2008 Jun 6.

PMID:
18535879
6.

Incremental prognostic value of myocardial SPET with dual-isotope rest (201)Tl/stress (99m)Tc-tetrofosmin.

Groutars RG, Verzijlbergen JF, Zwinderman AH, Tiel-Van Buul MM, Ascoop CA, van Hemel NM, van der Wall EE.

Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):46-52. Epub 2001 Oct 25.

PMID:
11807606
7.

Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization.

Schinkel AF, Elhendy A, Bax JJ, van Domburg RT, Huurman A, Valkema R, Biagini E, Rizzello V, Feringa HH, Krenning EP, Simoons ML, Poldermans D.

Am J Cardiol. 2006 Jan 1;97(1):1-6. Epub 2005 Nov 4.

PMID:
16377272
8.

Long-term prognostic value of Tc-99m tetrofosmin myocardial gated-SPECT imaging in asymptomatic patients after percutaneous coronary intervention.

Georgoulias P, Demakopoulos N, Tzavara C, Giannakou S, Valotassiou V, Tsougos I, Xaplanteris P, Fezoulidis I.

Clin Nucl Med. 2008 Nov;33(11):743-7. doi: 10.1097/RLU.0b013e318187ee88.

PMID:
18936603
9.

Comparison of exercise and pharmacological stress gated SPECT in detecting transient left ventricular dysfunction.

Demir H, Tan YZ, Isgoren S, Gorur GD, Kozdag G, Ural E, Berk F.

Ann Nucl Med. 2008 Jun;22(5):403-9. doi: 10.1007/s12149-008-0119-2. Epub 2008 Jul 4.

PMID:
18600418
10.

Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.

Beeres SL, Bax JJ, Dibbets P, Stokkel MP, Zeppenfeld K, Fibbe WE, van der Wall EE, Schalij MJ, Atsma DE.

J Nucl Med. 2006 Apr;47(4):574-80.

11.

Incremental prognostic value of (99m)Tc-tetrofosmin myocardial SPECT after percutaneous coronary intervention.

Georgoulias P, Tzavara C, Demakopoulos N, Giannakou S, Valotassiou V, Tsougos I, Xaplanteris P, Fezoulidis I.

Ann Nucl Med. 2008 Dec;22(10):899-909. doi: 10.1007/s12149-008-0191-7. Epub 2009 Jan 8.

PMID:
19142709
12.

Feasibility and diagnostic accuracy of a gated SPECT early-imaging protocol: a multicenter study of the Myoview Imaging Optimization Group.

Giorgetti A, Rossi M, Stanislao M, Valle G, Bertolaccini P, Maneschi A, Giubbini R, De Rimini ML, Mazzanti M, Cappagli M, Milan E, Volterrani D, Marzullo P; Myoview Imaging Optimization Group.

J Nucl Med. 2007 Oct;48(10):1670-5. Epub 2007 Sep 14.

14.

Incremental prognostic value of cardiac function assessed by ECG-gated myocardial perfusion SPECT for the prediction of future acute coronary syndrome.

Matsumoto N, Sato Y, Suzuki Y, Kasama S, Nakano Y, Kato M, Yoda S, Miki T, Iida J, Kunimasa T, Tadehara F, Nagao K, Hirayama A.

Circ J. 2008 Dec;72(12):2035-9. Epub 2008 Oct 24.

15.

[Technetium 99m tetrofosmin as a myocardial perfusion marker in diagnosis of coronary heart disease. Validation a one day rest-stress protocol].

Bair HJ, Altstidl R, Feistel H.

Rontgenpraxis. 1997 Sep;50(9):259-64. German. No abstract available.

PMID:
9411806
16.

Non-invasive diagnosis of in stent stenosis by stress 99m technetium tetrofosmin myocardial perfusion imaging.

Elhendy A, Schinkel AF, van Domberg RT, Bax JJ, Valkema R, Poldermans D.

Int J Cardiovasc Imaging. 2006 Oct;22(5):657-62. Epub 2006 Apr 21.

PMID:
16628382
18.

Early post-stress pulmonary uptake of 99mTc tetrofosmin during exercise (SPECT) myocardial perfusion imaging: correlation with haemodynamic, perfusion and function parameters.

Georgoulias P, Demakopoulos N, Kontos A, Xaplanteris P, Xydis K, Fezoylidis I.

Nucl Med Commun. 2006 Feb;27(2):119-26.

PMID:
16404224
19.

Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms.

Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Huurman A, Feringa HH, Poldermans D.

Am J Cardiol. 2006 Sep 1;98(5):585-90. Epub 2006 Jun 30.

PMID:
16923441
20.

Quantification of myocardial perfusion defects using three different software packages.

Svensson A, Akesson L, Edenbrandt L.

Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):229-32.

PMID:
15129705
Items per page

Supplemental Content

Write to the Help Desk